sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis.
Yingjie ZhaoXuezhi YangSiyu LiBingjie ZhangSusu LiXinwei WangYueye WangChengyan JiaYan ChangWei WeiPublished in: Stem cell research & therapy (2021)
sTNFRII-Fc modification protects MSCs against apoptosis/autophagy induced by TNF-α, in addition to releasing sTNFRII-Fc neutralizing TNF-α to block relevant immune-inflammation cascade, and thus exert better therapeutic effects in alleviating inflammatory arthritis.